Effect of aminoalkyl methacrylate copolymer E/ HCl on in vivo absorption of poorly water-soluble drug

References

• Brouwers J, Brewster ME, Augustijns P. (2009). Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci, 98:2549–2572.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Nakate T, Okimoto K, Ohike A, Tokunaga Y, Ibuki R et al. (2003). Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm, 267:79–91.
   PubMed Web of Science ®Google Scholar
• Gao P, Morozowich W. (2006). Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv, 3:97–110.
   PubMedGoogle Scholar
• Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D et al. (2004). Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev Ind Pharm, 30:303–317.
   PubMed Web of Science ®Google Scholar
• Ghebremeskel AN, Vemavarapu C, Lodaya M. (2007). Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. Int J Pharm, 328:119–129.
   PubMed Web of Science ®Google Scholar
• Overhoff KA, McConville JT, Yang W, Johnston KP, Peters JI, Williams RO 3rd. (2008). Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing. Pharm Res, 25:167–175.
   PubMed Web of Science ®Google Scholar
• Goddeeris C, Willems T, Houthoofd K, Martens JA, Van den Mooter G. (2008). Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100. Eur J Pharm Biopharm, 70:861–868.
   PubMed Web of Science ®Google Scholar
• Janssens S, Nagels S, Armas HN, D’Autry W, Van Schepdael A, Van den Mooter G. (2008). Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur J Pharm Biopharm, 69:158–166.
   PubMed Web of Science ®Google Scholar
• Shinde VR, Shelake MR, Shetty SS, Chavan-Patil AB, Pore YV, Late SG. (2008). Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique. J Pharm Pharmacol, 60:1121–1129.
   PubMed Web of Science ®Google Scholar
• Dave RH, Patel AD, Donahue E, Patel HH. (2012). To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin. Drug Dev Ind Pharm, 38:930–939.
   PubMed Web of Science ®Google Scholar
• Feng J, Xu L, Gao R, Luo Y, Tang X. (2012). Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm, 38:735–743.
   PubMed Web of Science ®Google Scholar
• Fouad EA, El-Badry M, Mahrous GM, Alanazi FK, Neau SH, Alsarra IA. (2011). The use of spray-drying to enhance celecoxib solubility. Drug Dev Ind Pharm, 37:1463–1472.
   PubMed Web of Science ®Google Scholar
• Jijun F, Lishuang X, Xiaoli W, Shu Z, Xiaoguang T, Xingna Z et al. (2011). Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm, 37:934–944.
   PubMed Web of Science ®Google Scholar
• He H, Yang R, Tang X. (2010). In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm, 36:681–687.
   PubMed Web of Science ®Google Scholar
• Curatolo W, Nightingale JA, Herbig SM. (2009). Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res, 26:1419–1431.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Hughey JR, Brough C, Miller DA, Williams RO 3rd, McGinity JW. (2010). Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing. Drug Dev Ind Pharm, 36:1064–1078.
   PubMed Web of Science ®Google Scholar
• Babcock WC, Curatolo WJ, Friesen DT, Ketner RJ, Lo JB. (2003). Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility enhancing polymer. PCT Int Appl WO 03000294, Jan 3.
   Google Scholar
• Tanno F, Nishiyama Y, Kokubo H, Obara S. (2004). Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug Dev Ind Pharm, 30:9–17.
   PubMed Web of Science ®Google Scholar
• Nakamichi K, Nakano T, Izumi T, Yasuura H, Kawashima Y. (2004). The preparation of enteric solid dispersions with hydroxypropylmethylcellulose acetate succinate using a twin-screw extruder. J Drug Del Sci Tech, 14:193–198.
   Web of Science ®Google Scholar
• Kennedy M, Hu J, Gao P, Li L, Ali-Reynolds A, Chal B et al. (2008). Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study. Mol Pharm, 5:981–993.
   PubMed Web of Science ®Google Scholar
• Jachowicz R, Czech A. (2008). Preparation and evaluation of piroxicam-HPMCAS solid dispersions for ocular use. Pharm Dev Technol, 13:495–504.
   PubMed Web of Science ®Google Scholar
• Al-Obaidi H, Buckton G. (2009). Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS. AAPS PharmSciTech, 10:1172–1177.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Yoshihara K, Umejima H, Kurimoto I. (2008). Aminoalkylmethacrylate copolymer E for maintaining solubility of poorly water-soluble drug. PCT Int Appl WO 08081829, Jul 10.
   Google Scholar
• Yoshida T, Kurimoto I, Yoshihara K, Umejima H, Ito N, Watanabe S et al. (2012). Aminoalkyl methacrylate copolymers for improving the solubility of tacrolimus. I: Evaluation of solid dispersion formulations. Int J Pharm, 428:18–24.
   PubMed Web of Science ®Google Scholar
• Chen YL, Hirabayashi H, Akhtar S, Pelzer M, Kobayashi M. (2006). Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 830:330–341.
   PubMed Web of Science ®Google Scholar
• Alasino RV, Leonhard V, Bianco ID, Beltramo DM. (2012). Eudragit E100 surface activity and lipid interactions. Colloids Surf B Biointerfaces, 91:84–89.
   PubMed Web of Science ®Google Scholar
• Asakura S, Oosawa F. (1954). Interaction between two bodies immersed in a solution of macromolecules. J Chem Phys, 22:1255–1256.
   Web of Science ®Google Scholar
• Doxastakis M, Chen YL, Guzmán O, de Pablo JJ. (2004). Polymer-particle mixtures: depletion and packing effects. J Chem Phys, 120:9335–9342.
   PubMed Web of Science ®Google Scholar
• Miller MA, DiNunzio J, Matteucci ME, Ludher BS, Williams RO, Johnston KP. (2012). Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability. Drug Dev Ind Pharm, 38:557–570.
   PubMed Web of Science ®Google Scholar